Overview
Funded in part by the National Institute of Neurological Disorders and Stroke (NINDS), RADARS (Rectal Administration of Diazepam for Acute Repetitive Seizures) was designed to assess the efficacy and safety of rectal diazepam gel (DiastatR) when administered by nonmedical personnel in non-acute care settings. RADARS is the first controlled study ever undertaken to examine at-home treatment of acute repetitive seizures (ARS), a serious cluster of seizures that if untreated can cause brain injury. Rectal diazepam gel also appears to increase quality-of-life and to be cost-effective, reducing the need for emergency room care.
Study Design
Key Findings
Efficacy
Safety
Benefits Of Rectal Diazepam Gel
New England Journal of Medicine